We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit

Delisted

MTACU was delisted on the 10th of August, 2023.

20 hedge funds and large institutions have $35M invested in MedTech Acquisition Corporation Unit in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3020 (-10)

50% less capital invested

Capital invested by funds: $69.7M → $35M (-$34.6M)

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13

80% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 10

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
20
Holders Change
-10
Holders Change %
-33.33%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
2
Reduced
10
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFS
26
Amtrust Financial Services
New York
-$752K -75,000 Closed
MS
27
Maven Securities
Jersey
-$502K -50,000 Closed
DCP
28
Diameter Capital Partners
New York
-$473K -47,200 Closed
WMSA
29
Weiss Multi-Strategy Advisers
New York
-$235K -23,484 Closed
CI Investments Inc
30
CI Investments Inc
Ontario, Canada
-$194K -19,400 Closed
RJA
31
Raymond James & Associates
Florida
-$160K -16,000 Closed
Walleye Capital
32
Walleye Capital
New York
-$124 -12,414 Closed
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
-$1K -111 Closed

MTACU Hedge Fund Activity: Q3 2021 in Review

20 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q3 2021, worth a combined $35M — down 50% from $69.7M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of MTACU and 3 opened new positions — a net loss of 10 holders — while 10 trimmed existing stakes and 2 added.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $3.13M. The largest seller was Hartree Partners, exiting entirely with an estimated $17.3M sold.

  • 20 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q3 2021, down from 30 in Q2 2021.
  • Funds reported $35M of MedTech Acquisition Corporation Unit stock for Q3 2021, down 50% quarter-over-quarter.
  • 3 funds opened new MedTech Acquisition Corporation Unit positions in Q3 2021 and 13 closed out, a net change of -10 holders.
  • The largest MedTech Acquisition Corporation Unit buyer in Q3 2021 was Gilder Gagnon Howe & Co, an estimated $3.13M added.
  • The largest MedTech Acquisition Corporation Unit seller in Q3 2021 was Hartree Partners, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2021.